ANI Pharmaceuticals
ANIP
ANIP
106 hedge funds and large institutions have $263M invested in ANI Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 46 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
35% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 46
48% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 21
Holders
106
Holding in Top 10
1
Calls
$415K
Puts
$400K
Top Buyers
1 | +$2.89M | |
2 | +$2.24M | |
3 | +$2.14M | |
4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.09M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.02M |
Top Sellers
1 | -$2.14M | |
2 | -$2.06M | |
3 | -$1.84M | |
4 |
Renaissance Technologies
New York
|
-$1.5M |
5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.08M |